XML 55 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2018   51,361        
Beginning balance at Dec. 31, 2018 $ 864,267 $ 5,136 $ 778,501 $ 97,074 $ (3,384) $ (13,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income 31,548     22,705   8,843
Stock based compensation expense 2,129   2,129      
Common stock transactions related to stock based employee benefit plans (in shares)   49        
Common stock transactions related to stock based employee benefit plans (1,584) $ 5 (14)   (1,575)  
Common stock issued for stock options (in shares)   4        
Common stock issued for stock options 64   64      
Increase (decrease) in shares during period (in shares)   53        
Increase (decrease) in stockholders' equity during period 32,157 $ 5 2,179 22,705 (1,575) 8,843
Ending balance (in shares) at Mar. 31, 2019   51,414        
Ending balance at Mar. 31, 2019 896,424 $ 5,141 780,680 119,779 (4,959) (4,217)
Beginning balance (in shares) at Dec. 31, 2019   51,514        
Beginning balance at Dec. 31, 2019 985,639 $ 5,151 786,242 195,813 (6,032) 4,465
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income 1,003     709   294
Stock based compensation expense 2,000   2,000      
Common stock transactions related to stock based employee benefit plans (in shares)   115        
Common stock transactions related to stock based employee benefit plans (1,410) $ 12 (32)   (1,390)  
Common stock issued for stock options (in shares)   37        
Common stock issued for stock options 400 $ 4 396      
Issuance of common stock, pursuant to acquisition (in shares)   1,043        
Issuance of common stock, pursuant to acquisition 21,031 $ 104 20,927      
Increase (decrease) in shares during period (in shares)   1,195        
Increase (decrease) in stockholders' equity during period 6,148 $ 120 23,291 (16,167) (1,390) 294
Ending balance (in shares) at Mar. 31, 2020   52,709        
Ending balance at Mar. 31, 2020 $ 991,787 $ 5,271 $ 809,533 $ 179,646 $ (7,422) $ 4,759